Addex Pharmaceuticals Announces Board Changes

Vincent Lawton appointed to Vice-Chairman

18-Aug-2011 - Switzerland

Addex Pharmaceuticals announced changes to the Company's Board of Directors. Vincent Lawton, an existing director at Addex, has been appointed Vice-Chairman.  In addition, Vincent Mutel formally resigned his position as Member of the Board of Directors of Addex. As previously announced, Dr. Mutel stepped down from his position as CEO of Addex on June 3, 2011.

Mr. Lawton, who was previously Managing Director of Merck Sharp & Dohme (MSD) U.K. and Vice President of MSD Europe, both subsidiaries of Merck & Co., Inc., has served on the Addex Board since April 2009.

Other news from the department people

Most read news

More news from our other portals

So close that even
molecules turn red...